Jan Pilch Selected Research

Jan Pilch Research Topics

Disease

16	Neoplasms (Cancer) 12/2017 - 06/2002
6	Neoplasm Metastasis (Metastasis) 02/2015 - 08/2003
4	Prostatic Neoplasms (Prostate Cancer) 12/2017 - 11/2011
2	Pathologic Constriction (Stenosis) 01/2018 - 01/2004
2	Thrombosis (Thrombus) 10/2013 - 06/2010
2	Melanoma (Melanoma, Malignant) 06/2010 - 06/2002
2	Laryngeal Neoplasms (Laryngeal Cancer) 01/2006 - 01/2006
2	Breast Neoplasms (Breast Cancer) 11/2003 - 08/2003
1	Body Weight (Weight, Body) 05/2021
1	COVID-19 05/2021
1	Inflammation (Inflammations) 02/2019
1	Hemophilia A (Haemophilia) 02/2019
1	Necrosis 02/2019
1	Carcinogenesis 12/2017
1	Kidney Neoplasms (Kidney Cancer) 01/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2015
1	Non-Muscle Invasive Bladder Neoplasms 02/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2013
1	Carcinoma (Carcinomatosis) 06/2010
1	Wounds and Injuries (Trauma) 02/2006
1	Neoplastic Processes 01/2006
1	Snoring 01/2003
1	Obstructive Sleep Apnea 01/2003
1	Circulating Neoplastic Cells 06/2002

Drug/Important Bio-Agent (IBA)

8	Fibronectins (Fibronectin)IBA 01/2015 - 06/2002
7	FibrinIBA 02/2015 - 02/2006
5	IntegrinsIBA 10/2013 - 06/2002
5	Peptides (Polypeptides)IBA 03/2012 - 11/2003
3	Integrin alphaVbeta3IBA 06/2010 - 06/2002
3	Blood Proteins (Serum Proteins)IBA 01/2007 - 06/2002
3	Fibrinogen (Factor I)FDA Link 02/2006 - 06/2002
2	AntibodiesIBA 05/2021 - 11/2003
2	Proteins (Proteins, Gene)FDA Link 02/2019 - 08/2003
2	rat CLIC1 proteinIBA 02/2015 - 02/2013
2	matrigelIBA 01/2015 - 11/2003
2	Fluorescein (Funduscein)FDA LinkGeneric 02/2013 - 02/2006
2	CytokinesIBA 01/2013 - 01/2006
1	Neutralizing AntibodiesIBA 05/2021
1	Immunoglobulin A (IgA)IBA 05/2021
1	Immunoglobulin G (IgG)IBA 05/2021
1	Macrophage Colony-Stimulating FactorIBA 02/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2019
1	LeptinIBA 02/2019
1	C-Reactive ProteinIBA 02/2019
1	Polyurethanes (Polyurethane)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 12/2017
1	HirudinsIBA 01/2015
1	rho-Associated KinasesIBA 01/2015
1	Y 27632IBA 01/2015
1	Thrombin FDA Link 01/2015
1	Transcription Factors (Transcription Factor)IBA 10/2013
1	Angiogenic ProteinsIBA 02/2013
1	ChloridesIBA 02/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2013
1	anastellinIBA 03/2012
1	Digoxin (Digitek)FDA LinkGeneric 02/2012
1	Bromodeoxyuridine (BrdU)IBA 02/2012
1	Androgen Receptors (Androgen Receptor)IBA 02/2012
1	Phenobarbital (Luminal)FDA Link 11/2011
1	AndrogensIBA 11/2011
1	Liposomes (Liposome)IBA 01/2007
1	Drug CarriersIBA 01/2007
1	estropipate (Ogen)FDA LinkGeneric 02/2006
1	Interleukin-10 (Interleukin 10)IBA 01/2006
1	Interleukin-2 (IL2)IBA 01/2006
1	A-factor (Streptomyces)IBA 01/2006
1	NucleolinIBA 11/2003
1	adhesion receptorIBA 08/2003
1	Matrix Metalloproteinases (MMPs)IBA 08/2003
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2003
1	VitronectinIBA 08/2003
1	Metalloproteases (Metalloproteinases)IBA 08/2003
1	Integrin alphaVIBA 06/2002
1	BuffersIBA 06/2002
1	SuspensionsIBA 06/2002
1	LigandsIBA 06/2002
1	von Willebrand FactorIBA 06/2002

Therapy/Procedure

4	Therapeutics 11/2011 - 01/2004
2	Castration 12/2017 - 02/2012
1	Plasmapheresis 05/2021
1	Aftercare (After-Treatment) 02/2019
1	Ligation 02/2013
1	Radiotherapy 01/2006
1	Operative Surgical Procedures 01/2006
1	Tracheotomy 01/2004
1	Lasers (Laser) 01/2003